Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note published on Monday morning. The firm issued a sell rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Stock Performance

Shares of STRM stock opened at $2.92 on Monday. Streamline Health Solutions has a one year low of $1.85 and a one year high of $9.75. The stock has a market cap of $12.33 million, a P/E ratio of -0.59 and a beta of 1.64. The company has a fifty day moving average price of $2.62 and a two-hundred day moving average price of $5.41. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61.

Streamline Health Solutions (NASDAQ:STRM) last posted its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The company had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.